24GlaxoSmithKline Pharmaceuticals SA子公司100.00% 25SmithKline Beecham Limited子公司100.00% 26ViiV Healthcare Kabushiki Kaisha (Japan)子公司78.30% 27GlaxoSmithKline Consumer Healthcare S.p.A. (Italy)子公司68.00% 28GlaxoSmithKline Research & Development Limited子公司100.00% ...
1.WasistClamoxylundwofürwirdesangewendet? WasistClamoxyl ClamoxylisteinAntibiotikum.DasPulverenthälteinenWirkstoffnamensAmoxicillin.Diesergehört zueinerGruppevonArzneimitteln,die„Penicilline”genanntwerden. WofürwirdClamoxylangewendet Clamoxylwirdangewendet,umvonBakterienverursachteInfektionenanverschiedenen...
Hikma Pharmaceuticals ― ― GNS Genus plc ― ― FUM Futura Medical ― ― Compare GB:GSK Stocks > Best Analysts Covering GSK Graham ParryBank of America Securities 1 Year Success Rate 10/17 ratings generated profit 1 Year Average Return
20070197478 NOVEL PHARMACEUTICALS 2007-08-23 Jones et al. 20070190071 9-Substituted 8-oxoadenine compound 2007-08-16 Kurimoto et al. 20060264448 Purine derivatives 2006-11-23 Pryde 7126880 Radio wristwatch 2006-10-24 Chen 20060148805 Opthalmic compositions for treating ocular hypertension 2006-07-...
As used herein, the term “process impurities” may be defined as per International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines (e.g. ICH Q6B), and is taken to refer to impurities that are present as a result of the ...
Short Interest: Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), GlaxoSmithKline (GSK), Mobileye (MBLY), The WhiteWave Foods Company (WWAV)
7691877 Pharmaceuticals 2010-04-06 Jones et al. 20100056031 Polishing Pad 2010-03-04 Chiu et al. 20090232844 IMMUNOPOTENTIATING COMPOUNDS 2009-09-17 Sutton 424/209.1 20090221631 IMIDAZOPYRIDINONES 2009-09-03 Jones et al. 20090208523 Adjuvant for vaccines 2009-08-20 Broeker 20090192153 NOVEL ADENINE...